Supplemental material
Emerging Microbes & Infections
Volume 12, 2023 - Issue 1
Coronaviruses
HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19
, , , , , , , , 
, , , , & show all
Xiaoduo Xiee Department of Biochemistry, School of Medicine, Sun Yat-sen University, Shenzhen, People’s Republic of Chinahttps://orcid.org/0000-0003-0610-8007View further author information
https://orcid.org/0000-0003-0610-8007View further author information, Tao Chenb State Key Laboratory of Respiratory Disease at People’s Hospital of Yangjiang, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of Chinahttps://orcid.org/0000-0002-8433-2509View further author information
https://orcid.org/0000-0002-8433-2509View further author information, Hui Zhangf Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry of Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, People’s Republic of Chinahttps://orcid.org/0000-0003-3620-610XView further author information
https://orcid.org/0000-0003-3620-610XView further author information, Yi-Xin Zenga Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of Chinahttps://orcid.org/0000-0002-6515-628XView further author information
https://orcid.org/0000-0002-6515-628XView further author information, Jincun Zhaob State Key Laboratory of Respiratory Disease at People’s Hospital of Yangjiang, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou, People’s Republic of Chinahttps://orcid.org/0000-0003-2515-5589View further author information
https://orcid.org/0000-0003-2515-5589View further author information & Lin Fenga Department of Experimental Research, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of ChinaCorrespondence[email protected]
https://orcid.org/0000-0001-6461-5838View further author information
https://orcid.org/0000-0001-6461-5838View further author information show all